Carcinoembryonic antigen

Results: 20



#Item
110C007-3  CEA-Scan® (Arcitumomab

10C007-3 CEA-Scan® (Arcitumomab

Add to Reading List

Source URL: pharmacyce.unm.edu

Language: English - Date: 2016-08-17 16:06:15
2Hybrid cells derived from breast epithelial cell/breast cancer cell fusion events show a differential RAF-AKT crosstalk

Hybrid cells derived from breast epithelial cell/breast cancer cell fusion events show a differential RAF-AKT crosstalk

Add to Reading List

Source URL: www.biosignaling.com

Language: English
3Microsoft Word - FINAL CEA Report dated 22 July 2005 amendments to proof.doc

Microsoft Word - FINAL CEA Report dated 22 July 2005 amendments to proof.doc

Add to Reading List

Source URL: www.otago.ac.nz

Language: English
4Microsoft Word - FINAL CEA Report dated 22 July 2005 amendments to proof.doc

Microsoft Word - FINAL CEA Report dated 22 July 2005 amendments to proof.doc

Add to Reading List

Source URL: www.msac.gov.au

Language: English - Date: 2014-08-08 00:29:21
5Immune system / Oncology / Biomarkers / Prostate-specific antigen / CA-125 / Breast cancer / Prostate cancer / Ovarian cancer / Carcinoembryonic antigen / Medicine / Tumor markers / Ribbon symbolism

DOC Document

Add to Reading List

Source URL: precedings.nature.com

Language: English
6Hindawi Publishing Corporation BioMed Research International Volume 2013, Article ID[removed], 9 pages http://dx.doi.org[removed][removed]Review Article

Hindawi Publishing Corporation BioMed Research International Volume 2013, Article ID[removed], 9 pages http://dx.doi.org[removed][removed]Review Article

Add to Reading List

Source URL: downloads.hindawi.com

Language: English - Date: 2014-03-26 07:44:56
7ORIGINAL ARTICLE  Comparative Analysis of Tumor Cell Dissemination in Mesenteric, Central, and Peripheral Venous Blood in Patients With Colorectal Cancer Moritz Koch, MD; Ju¨rgen Weitz, MD; Peter Kienle, MD; Arel Benner

ORIGINAL ARTICLE Comparative Analysis of Tumor Cell Dissemination in Mesenteric, Central, and Peripheral Venous Blood in Patients With Colorectal Cancer Moritz Koch, MD; Ju¨rgen Weitz, MD; Peter Kienle, MD; Arel Benner

Add to Reading List

Source URL: archsurg.jamanetwork.com

Language: English
8PRODUCT HIGHLIGHT  28 – September 2014

PRODUCT HIGHLIGHT 28 – September 2014

Add to Reading List

Source URL: www.cli-online.com

Language: English - Date: 2014-11-13 08:03:13
9T Cell Immunotherapy - Optimizing Trial Design Office of Biotechnology Activities September 10, 2013 Target selection  Steven A. Rosenberg, M.D., Ph.D.

T Cell Immunotherapy - Optimizing Trial Design Office of Biotechnology Activities September 10, 2013 Target selection Steven A. Rosenberg, M.D., Ph.D.

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-09 16:17:27
10ANTIGENS AND TOXICITY WITH DESIGNER T CELLS Under FDA/OBA: CEA, PSMA Foreign experience: G250, CEA, CD19, LeY  Richard P Junghans, PhD, MD

ANTIGENS AND TOXICITY WITH DESIGNER T CELLS Under FDA/OBA: CEA, PSMA Foreign experience: G250, CEA, CD19, LeY Richard P Junghans, PhD, MD

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-08 13:16:23